Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by Ingiboyon Oct 15, 2022 10:28am
80 Views
Post# 35026605

RE:RE:RE:Excitement starting??

RE:RE:RE:Excitement starting??
MetzGER wrote: This theory about the 1 Year arbitration was a Big joke. Lee Buckler was checking this Forum and laughing about us being so stupid to believe that Shiseido arbitration would be resolved within 1 year.

i am so Angry about myself believing that this october the nightmare would be over. I am a fking idiot!!!



Those that follow Replicel closely may have been mislead about the Arbitration having a time limit of 1 year.
Here is a link to the rules for the International Center for Dispute  Resolution

https://www.icdr.org/sites/default/files/document_repository/ICDR_Rules_1.pdf?utm_source=icdr-website&utm_medium=rules-page&utm_campaign=rules-intl-update-1mar

I have read this thoroughly and fail to see any reference to a 1 year time limit of the Arbitration.  I may be wrong.

The key part of the Arbitration process is the Hearing (Article 26). Once the Hearing takes place:
  1. "the final award shall be made no later than 60 days from the date of the closing of the hearing pursuant to Article 30. "

    The key question here is has the Hearing taken place and if not why ?
     In that regard when you read Article 40 Confidentiality there is no reference to preventing the company from keeping the shareholders informed about what stage the Arbitration process is in.



     



<< Previous
Bullboard Posts
Next >>